ImmuCell Corporation Refinances Debt with New Loan from Maine Community Bank, Reducing Interest Rates and Extending Amortization Schedule
ImmuCell Corporation, a prominent player in the animal health sector, has announced the successful refinancing of a portion of its bank debt. The company secured a new loan from Maine Community Bank amounting to $2,327,119 at a fixed interest rate of 6.5% per annum. This new loan was utilized to pay off existing loans with higher interest rates, specifically a loan with a 7% interest rate from MCB and another with an 8% rate from the Finance Authority of Maine. The repayment of these loans, which included significant balloon principal payments due in 2026, positions ImmuCell more favorably for future financial planning. The new loan comes with a five-year amortization schedule, extending through the third quarter of 2030, enhancing the company's financial flexibility.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ImmuCell Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-074983), on August 12, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。